相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Persistent Ethnicity-Associated Disparity in Antitumor Effectiveness of Immune Checkpoint Inhibitors Despite Equal Access
Marcus A. Florez et al.
CANCER RESEARCH COMMUNICATIONS (2022)
Efficacy and safety of immune checkpoint blockade in self-identified black patients with advanced non-small cell lung cancer
Bassel Nazha et al.
CANCER (2020)
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
M. A. Socinski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer et al.
LANCET (2017)
Comparative Transcriptome Profiling Reveals Coding and Noncoding RNA Differences in NSCLC from African Americans and European Americans
Khadijah A. Mitchell et al.
CLINICAL CANCER RESEARCH (2017)
Bias and Sensitivity Analysis When Estimating Treatment Effects from the Cox Model with Omitted Covariates
Nan Xuan Lin et al.
BIOMETRICS (2013)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Unlimited access to care: Effect on racial disparity and prognostic factors in lung cancer
CR Mulligan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Propensity score estimation with boosted regression for evaluating causal effects in observational studies
DF McCaffrey et al.
PSYCHOLOGICAL METHODS (2004)
Genetic variation, classification and 'race'
LB Jorde et al.
NATURE GENETICS (2004)
Racial differences in lung cancer
SM Gadgeel et al.
CANCER AND METASTASIS REVIEWS (2003)
分享论文
